1. Nora D. Prescription Opioid and Heroin Abuse. Presentation included IMS Health, Vector One source data of National Prescription Audit, years 1997-2013, delivered at 2014 Testimony to U.S. Congress, House Committee on Energy and Commerce Subcommittee on Oversight and Investigations. Available at https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2016/prescription-opioid-heroin-abuse .
2. Volkow N. Characteristics of Opioid Prescriptions in 2009. JAMA. 2011;305(13):1299.
3. U.S. Department of Health and Human Services. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality; 2014. Available at https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf .
4. Center for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, Mortality File. Number and Age-Adjusted Rates of Drug-poisoning Deaths Involving Opioid Analgesics and Heroin: United States, 2000–2014. Atlanta: Center for Disease Control and Prevention; 2015. Available at https://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf .
5. Florence C, Zhou C, Luo F, Xu L. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013. Med Care. 2016;54(10):901–6.